Literature DB >> 26232080

Polyelectrolyte complexes of hTERT siRNA and polyethyleneimine: Effect of degree of PEG grafting on biological and cellular activity.

Fatemeh Safari1, Ali M Tamaddon2, Nosratollah Zarghami1, S Abolmali2, Abolfazl Akbarzadeh1.   

Abstract

Gene silencing by siRNA (short interfering RNA)-targeted human telomerase reverse transcriptase (hTERT) is considered a successful strategy for cancer gene therapy. Polyelectrolyte complexes (PEC) of siRNA and cationic polymers such as polyethyleneimine (PEI) have been widely used for cellular transfection; however, they demonstrate some disadvantages such as cytotoxicity and extracellular matrix restrictions. PEG grafting technology was used in an attempt to improve the biocompatibility of PECs. Considering that this technology may compromise the cellular uptake of PECs, we aimed to study the effect of degree of PEI PEGylation on the carrier cytotoxicity, cellular association, and transfection efficiency of hTERT siRNA in the lung cancer cell line A549. Activated NHS ester of methoxy PEG-COOH 5 KDa was grafted to hyperbranched PEI 25 KDa in the molar ratios of 0.2 and 1. The copolymers were characterized by (1)H-NMR spectroscopy. PECs of PEI or PEG-g-PEI with siRNA, alone or co-incubated with heparin sulfate, were studied by the ethidium bromide exclusion assay. Cytotoxicity of the polymers (PEG-g-PEI vs PEI), alone and upon formation of PEC nanoparticles with hTERT siRNA, was determined by a validated MTT assay, in comparison to a scrambled control sequence, in A549 human lung carcinoma cells. The cellular uptake of the PECs of FITC-labeled siRNA was investigated by flow cytometry at different N/P ratios, and the silencing effect of the transfected siRNA was compared to that of the control sequence for different PECs by real time RT-PCR. The cytotoxicity of PEI decreased significantly by PEG grafting, even at a low degree of PEGylation. Moreover, the nonspecific cytotoxicity of PECs decreased by PEG grafting. PECs of PEG-g-PEI showed more biologic stability on incubation with heparin sulfate. Average particle size and zeta potential of PEC nanoparticles were diminished for those of PEG-g-PEI. The cellular association was more pronounced at an N/P ratio of 2.5 for PECs of PEI and PEG-g-PEI alike. The level of silencing of hTERT mRNA by PEC of PEG-g-PEI was sequence-dependent, and determined non-inferior when compared to the native PEI. Conclusively, the biocompatibility of PEI was improved by a low degree of PEGylation, with no adverse effect on the cellular uptake and the transfection activity. PEC nanoparticles of hTERT siRNA and PEG-g-PEI could act as a promising weapon against A549 cells, which has to be considered for an in vivo evaluation.

Entities:  

Keywords:  FITC-labeled; PEGylation; gene silencing; hTERT; zeta potential

Mesh:

Substances:

Year:  2015        PMID: 26232080     DOI: 10.3109/21691401.2015.1064936

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  4 in total

Review 1.  CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease.

Authors:  Fatemeh Safari; Gholamreza Hatam; Abbas Behzad Behbahani; Vahid Rezaei; Mazyar Barekati-Mowahed; Peyman Petramfar; Farzaneh Khademi
Journal:  Cell Mol Neurobiol       Date:  2019-11-26       Impact factor: 5.046

2.  Caspase-7 deficiency in Chinese hamster ovary cells reduces cell proliferation and viability.

Authors:  Fatemeh Safari; Safar Farajnia; Abbas Behzad Behbahani; Habib Zarredar; Mazyar Barekati-Mowahed; Hesam Dehghani
Journal:  Biol Res       Date:  2020-11-13       Impact factor: 5.612

Review 3.  Polymeric Carriers for Delivery of RNA Cancer Therapeutics.

Authors:  Sofía Mirón-Barroso; Joana S Correia; Adam E Frampton; Mark P Lythgoe; James Clark; Laura Tookman; Silvia Ottaviani; Leandro Castellano; Alexandra E Porter; Theoni K Georgiou; Jonathan Krell
Journal:  Noncoding RNA       Date:  2022-08-02

4.  Strategies for Improving siRNA-Induced Gene Silencing Efficiency.

Authors:  Fatemeh Safari; Solmaz Rahmani Barouji; Ali Mohammad Tamaddon
Journal:  Adv Pharm Bull       Date:  2017-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.